| Viatris Pharma GmbH - Influvac Tetra 0.5 ml, Injektionssuspension | | 68087 | | 04 | | Influvac Tetra 0.5 ml | | Injektionssuspension | | J07BB02 | | Influenza, Inactivated, Split Virus Or Surface Antigen | | 07.08.2024 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) (Virus-Stamm A/Victoria/4897/2022 (H1N1)-pdm09: reassortant virus IVR-238 derived from A/Victoria/4897/2022) 15 µg, haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Thailand/8/2022 (H3N2)-like: reassortant virus derived from A/California/122/2022, SAN-022) 15 µg, haemagglutininum influenzae B (Virus-Stamm B/Austria/1359417/2021 -like: reassortant virus BVR-26 derived from B/Austria/1359417/2021 (Victoria lineage)) 15 µg, haemagglutininum influenzae B (Virus-Stamm B/Phuket/3073/2013 (Yamagata lineage)) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 2.01 mg, kalium 0.08 mg, residui: cetrimidum, formaldehydum, gentamicini sulfas, polysorbatum 80, ovalbuminum. | | Packungsbestandteile | | | | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 009 | | 9.58 | 26.85 | B | SL | No | | 010 | 10 | PR | PR | B | | No |
|
|
